# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001104659-23-110119
Filing Date
2023-10-19
Accepted
2023-10-19 16:23:37
Documents
74
Period of Report
2023-10-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | tm2328542d1_8k.htm iXBRL | 8-K | 39482
2 | EXHIBIT 99.1 | tm2328542d1_ex99-1.htm | EX-99.1 | 29173
3 | EXHIBIT 99.2 | tm2328542d1_ex99-2.htm | EX-99.2 | 29142
4 | EXHIBIT 99.3 | tm2328542d1_ex99-3.htm | EX-99.3 | 53888
9 | GRAPHIC | tm2328542d1_ex99-1img001.jpg | GRAPHIC | 2199
10 | GRAPHIC | tm2328542d1_ex99-1img002.jpg | GRAPHIC | 14897
11 | GRAPHIC | tm2328542d1_ex99-1img003.jpg | GRAPHIC | 28498
12 | GRAPHIC | tm2328542d1_ex99-2img001.jpg | GRAPHIC | 170370
13 | GRAPHIC | tm2328542d1_ex99-2img002.jpg | GRAPHIC | 624725
14 | GRAPHIC | tm2328542d1_ex99-2img003.jpg | GRAPHIC | 410916
15 | GRAPHIC | tm2328542d1_ex99-2img004.jpg | GRAPHIC | 249952
16 | GRAPHIC | tm2328542d1_ex99-2img005.jpg | GRAPHIC | 362009
17 | GRAPHIC | tm2328542d1_ex99-2img006.jpg | GRAPHIC | 370581
18 | GRAPHIC | tm2328542d1_ex99-2img007.jpg | GRAPHIC | 319498
19 | GRAPHIC | tm2328542d1_ex99-2img008.jpg | GRAPHIC | 382997
20 | GRAPHIC | tm2328542d1_ex99-2img009.jpg | GRAPHIC | 166333
21 | GRAPHIC | tm2328542d1_ex99-2img010.jpg | GRAPHIC | 229705
22 | GRAPHIC | tm2328542d1_ex99-2img011.jpg | GRAPHIC | 136573
23 | GRAPHIC | tm2328542d1_ex99-2img012.jpg | GRAPHIC | 207979
24 | GRAPHIC | tm2328542d1_ex99-2img013.jpg | GRAPHIC | 169521
25 | GRAPHIC | tm2328542d1_ex99-2img014.jpg | GRAPHIC | 197820
26 | GRAPHIC | tm2328542d1_ex99-2img015.jpg | GRAPHIC | 138159
27 | GRAPHIC | tm2328542d1_ex99-2img016.jpg | GRAPHIC | 362638
28 | GRAPHIC | tm2328542d1_ex99-2img017.jpg | GRAPHIC | 237933
29 | GRAPHIC | tm2328542d1_ex99-2img018.jpg | GRAPHIC | 332373
30 | GRAPHIC | tm2328542d1_ex99-2img019.jpg | GRAPHIC | 320398
31 | GRAPHIC | tm2328542d1_ex99-2img020.jpg | GRAPHIC | 351492
32 | GRAPHIC | tm2328542d1_ex99-2img021.jpg | GRAPHIC | 154045
33 | GRAPHIC | tm2328542d1_ex99-3img001.jpg | GRAPHIC | 32782
34 | GRAPHIC | tm2328542d1_ex99-3img002.jpg | GRAPHIC | 160848
35 | GRAPHIC | tm2328542d1_ex99-3img003.jpg | GRAPHIC | 107138
36 | GRAPHIC | tm2328542d1_ex99-3img004.jpg | GRAPHIC | 85726
37 | GRAPHIC | tm2328542d1_ex99-3img005.jpg | GRAPHIC | 45794
38 | GRAPHIC | tm2328542d1_ex99-3img006.jpg | GRAPHIC | 60195
39 | GRAPHIC | tm2328542d1_ex99-3img007.jpg | GRAPHIC | 53567
40 | GRAPHIC | tm2328542d1_ex99-3img008.jpg | GRAPHIC | 80716
41 | GRAPHIC | tm2328542d1_ex99-3img009.jpg | GRAPHIC | 64032
42 | GRAPHIC | tm2328542d1_ex99-3img010.jpg | GRAPHIC | 51224
43 | GRAPHIC | tm2328542d1_ex99-3img011.jpg | GRAPHIC | 95378
44 | GRAPHIC | tm2328542d1_ex99-3img012.jpg | GRAPHIC | 84256
45 | GRAPHIC | tm2328542d1_ex99-3img013.jpg | GRAPHIC | 68268
46 | GRAPHIC | tm2328542d1_ex99-3img014.jpg | GRAPHIC | 78608
47 | GRAPHIC | tm2328542d1_ex99-3img015.jpg | GRAPHIC | 66972
48 | GRAPHIC | tm2328542d1_ex99-3img016.jpg | GRAPHIC | 57741
49 | GRAPHIC | tm2328542d1_ex99-3img017.jpg | GRAPHIC | 78686
50 | GRAPHIC | tm2328542d1_ex99-3img018.jpg | GRAPHIC | 113917
51 | GRAPHIC | tm2328542d1_ex99-3img019.jpg | GRAPHIC | 50541
52 | GRAPHIC | tm2328542d1_ex99-3img020.jpg | GRAPHIC | 87123
53 | GRAPHIC | tm2328542d1_ex99-3img021.jpg | GRAPHIC | 62441
54 | GRAPHIC | tm2328542d1_ex99-3img022.jpg | GRAPHIC | 54924
55 | GRAPHIC | tm2328542d1_ex99-3img023.jpg | GRAPHIC | 64959
56 | GRAPHIC | tm2328542d1_ex99-3img024.jpg | GRAPHIC | 107064
57 | GRAPHIC | tm2328542d1_ex99-3img025.jpg | GRAPHIC | 67070
58 | GRAPHIC | tm2328542d1_ex99-3img026.jpg | GRAPHIC | 43536
59 | GRAPHIC | tm2328542d1_ex99-3img027.jpg | GRAPHIC | 76536
60 | GRAPHIC | tm2328542d1_ex99-3img028.jpg | GRAPHIC | 70695
61 | GRAPHIC | tm2328542d1_ex99-3img029.jpg | GRAPHIC | 72199
62 | GRAPHIC | tm2328542d1_ex99-3img030.jpg | GRAPHIC | 25625
63 | GRAPHIC | tm2328542d1_ex99-3img031.jpg | GRAPHIC | 62377
64 | GRAPHIC | tm2328542d1_ex99-3img032.jpg | GRAPHIC | 85168
65 | GRAPHIC | tm2328542d1_ex99-3img033.jpg | GRAPHIC | 107154
66 | GRAPHIC | tm2328542d1_ex99-3img034.jpg | GRAPHIC | 29751
| Complete submission text file | 0001104659-23-110119.txt |  | 11947732

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA | aeon-20231019.xsd | EX-101.SCH | 3369
6 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | aeon-20231019_def.xml | EX-101.DEF | 26941
7 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | aeon-20231019_lab.xml | EX-101.LAB | 36508
8 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | aeon-20231019_pre.xml | EX-101.PRE | 25565
68 | EXTRACTED XBRL INSTANCE DOCUMENT | tm2328542d1_8k_htm.xml | XML | 5005

Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40021 | Film No.: 231334961
SIC: 2834 Pharmaceutical Preparations